Daily non-political popular news in brief.

HIV persists in the gut despite long-term HIV therapy

Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs.

Read more »

Keywords: hiv, persists, gut, despite, long-term, therapy, persist, long, term

« Previous | Next »

Similar news on "HIV persists in the gut despite long-term HIV therapy":

1. Breast cancer survivors experience long-term heart disease risk from radiotherapy
   03-06-2007 · EurekAlert!
   Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute. Despite this increased risk of heart disease, radiation therapy has been previously shown to improve the chances of surviving breast cancer.
   Similar news · Read more »
   
2. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
   11-05-2006 · EurekAlert!
   New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
   Similar news · Read more »
   
3. Racial disparities persist in cancer care
   01-07-2008 · EurekAlert!
   A new study finds that, despite efforts in the last decade to mitigate cancer treatment disparities, black patients are significantly less likely than white patients to receive therapy for various types of cancer.
   Similar news · Read more »
   
4. Testing delays cause severe AIDS complications, Einstein researchers find
   11-02-2007 · EurekAlert!
   Despite the availability of life-saving antiretroviral treatment, people infected with HIV continue to die and suffer from complications of AIDS, mainly due to delayed diagnosis and initiation of treatment. A researcher at the Albert Einstein College of Medicine of Yeshiva University and colleagues at Yale University have shed light on why this problem persists. They report their findings in the November issue of the journal Medical Care.
   Similar news · Read more »
   
5. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
   12-20-2007 · EurekAlert!
   The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
   Similar news · Read more »
   
6. Germany Sets Out To Develop Global HIV Cryobank
   10-06-2006 · ScienceDaily
   The HIV virus still poses unsolved problems. Despite decades of research, no vaccine yet exists. An international project supported by the Gates Foundation, Fraunhofer, and the Ministry of Economic Affairs of Saarland in Germany has set out to develop a global HIV cryobank.
   Similar news · Read more »
   
7. MERLIN TIMI-36 study provides new safety & efficacy data for unique anti-anginal therapy
   03-27-2007 · EurekAlert!
   Chest pain due to a shortage of blood in the heart, known as angina, is a condition that affects millions of Americans. The most recently approved new pharmaceutical approach to treat chronic angina is a novel drug called ranolazine, which was approved in 2006 for use as second line therapy in patients who continue to experience angina despite treatment with another class of anti-anginal medication.
   Similar news · Read more »
   
8. Even older women at high risk have little interest in being tested for HIV, study finds
   08-07-2007 · EurekAlert!
   Few older women were interested in being tested for the virus that causes AIDS despite significant risk factors for lifetime exposure, according to a study published in the Journal of Women's Health. The risk is especially great among African-American women, who represent 73 percent of new HIV cases in women over age 50. "Older people have been overlooked in HIV prevention programs," notes lead author Aletha Akers, M.D., University of Pittsburgh School of Medicine.
   Similar news · Read more »
   
9. Keeping cancer at bay: Long-term therapy in the fight against multiple myeloma
   11-03-2006 · EurekAlert!
   There is no known cure for multiple myeloma, so its diagnosis means high-dose chemotherapy followed by repeated treatments with each relapse of the cancer -- a watch and wait approach. A new approach of providing patients with continuous therapy to keep the cancer at bay was explored by a team of international researchers from France, Switzerland and Belgium. Their findings will be published in the Nov. 15, 2006, issue of Blood.
   Similar news · Read more »
   
10. Radiation therapy combo cures prostate cancer long-term
    01-04-2007 · EurekAlert!
    Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
    Similar news · Read more »